Venous thrombosis in children

References

• Andrew M, David M, Adams M et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood83(5), 1251–1257 (1994).
   PubMed Web of Science ®Google Scholar
• Coon WW, Willis PW 3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation48(4), 839–846 (1973).
   PubMed Web of Science ®Google Scholar
• Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin. Thromb. Haemost.63(1), 27–30 (1990).
   PubMed Web of Science ®Google Scholar
• Andrew M, Mitchell L, Vegh P, Ofosu F. Thrombin regulation in children differs from adults in the absence and presence of heparin. Thromb. Haemost.72(6), 836–842 (1994).
   PubMed Web of Science ®Google Scholar
• Nitschmann E, Berry L, Bridge S et al. Morphological and biochemical features affecting the antithrombotic properties of the aorta in adult rabbits and rabbit pups. Thromb. Haemost.79(5), 1034–1040 (1998).
   PubMed Web of Science ®Google Scholar
• Kuhle S, Massicotte P, Chan A et al. Systemic thromboembolism in children. Data from the 1–800-NO-CLOTS Consultation Service. Thromb. Haemost.92(4), 722–728 (2004).
   PubMed Web of Science ®Google Scholar
• Montes de Oca MA, Babron MC, Bletry O et al. Thrombosis in systemic lupus erythematosus: a French collaborative study. Arch. Dis. Child.66(6), 713–717 (1991).
   PubMed Web of Science ®Google Scholar
• Berube C, Mitchell L, Silverman E et al. The relationship of antiphospholipid antibodies to thromboembolic events in pediatric patients with systemic lupus erythematosus: a cross-sectional study. Pediatr. Res.44(3), 351–356 (1998).
   PubMed Web of Science ®Google Scholar
• Andrew M, Marzinotto V, Pencharz P et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J. Pediatr.126(3), 358–363 (1995).
   PubMed Web of Science ®Google Scholar
• Marsh D, Wilkerson SA, Cook LN, Pietsch JB. Right atrial thrombus formation screening using two-dimensional echocardiograms in neonates with central venous catheters. Pediatrics81(2), 284–286 (1988).
   PubMed Web of Science ®Google Scholar
• Krafte-Jacobs B, Sivit CJ, Mejia R, Pollack MM. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J. Pediatr.126(1), 50–54 (1995).
   PubMed Web of Science ®Google Scholar
• Beck C, Dubois J, Grignon A, Lacroix J, David M. Incidence and risk factors of catheter-related deep vein thrombosis in a pediatric intensive care unit: a prospective study. J. Pediatr.133(2), 237–241 (1998).
   PubMed Web of Science ®Google Scholar
• Male C, Chait P, Ginsberg JS et al. Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase. Thromb. Haemost.87(4), 593–598 (2002).
   PubMed Web of Science ®Google Scholar
• Price VE, Carcao M, Connolly B et al. A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia. J. Thromb. Haemost.2(5), 737–742 (2004).
   PubMed Web of Science ®Google Scholar
• Manco-Johnson MJ, Grabowski EF, Hellgreen M et al. Recommendations for tPA thrombolysis in children. On behalf of the Scientific Subcommittee on Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis. Thromb. Haemost.88(1), 157–158 (2002).
   PubMed Web of Science ®Google Scholar
• Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics96(5 Pt 1), 939–943 (1995).
   PubMed Web of Science ®Google Scholar
• Berkun Y, Padeh S, Barash J et al. Antiphospholipid syndrome and recurrent thrombosis in children. Arthritis Rheum.55(6), 850–855 (2006).
   PubMed Web of Science ®Google Scholar
• van Ommen CH, Heijboer H, van den Dool EJ, Hutten BA, Peters M. Pediatric venous thromboembolic disease in one single center: congenital prothrombotic disorders and the clinical outcome. J. Thromb. Haemost.1(12), 2516–2522 (2003).
   PubMed Web of Science ®Google Scholar
• van Ommen CH, Heijboer H, Buller HR, Hirasing RA, Heijmans HS, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J. Pediatr.139(5), 676–681 (2001).
   PubMed Web of Science ®Google Scholar
• Bonduel M, Hepner M, Sciuccati G et al. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism. Thromb. Haemost.87(6), 972–977 (2002).
   PubMed Web of Science ®Google Scholar
• Hagstrom JN, Walter J, Bluebond-Langner R, Amatniek JC, Manno CS, High KA. Prevalence of the factor V leiden mutation in children and neonates with thromboembolic disease. J. Pediatr.133(6), 777–781 (1998).
   PubMed Web of Science ®Google Scholar
• Lawson SE, Butler D, Enayat MS, Williams MD. Congenital thrombophilia and thrombosis: a study in a single centre. Arch. Dis. Child.81(2), 176–178 (1999).
   PubMed Web of Science ®Google Scholar
• Heller C, Becker S, Scharrer I, Kreuz W. Prothrombotic risk factors in childhood stroke and venous thrombosis. Eur. J. Pediatr.158Suppl 3 S117–121 (1999).
   PubMed Web of Science ®Google Scholar
• Nowak-Gottl U, Junker R, Kreuz W et al. Risk of recurrent venous thrombosis in children with combined prothrombotic risk factors. Blood97(4), 858–862 (2001).
   PubMed Web of Science ®Google Scholar
• Vossen CY, Conard J, Fontcuberta J et al. Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT). J. Thromb. Haemost.3(3), 459–464 (2005).
   PubMed Web of Science ®Google Scholar
• David M, Manco-Johnson M, Andrew M. Diagnosis and treatment of venous thromboembolism in children and adolescents. On behalf of the Subcommittee on Perinatal Haemostasis of the Scientific and Standardization Committee of the ISTH. Thromb. Haemost.74(2), 791–792 (1995).
   PubMed Web of Science ®Google Scholar
• Kearon C, Julian JA, Newman TE, Ginsberg JS. Noninvasive diagnosis of deep venous thrombosis. McMaster Diagnostic Imaging Practice Guidelines Initiative. Ann. Intern. Med.128(8), 663–677 (1998).
   PubMed Web of Science ®Google Scholar
• Cogo A, Lensing AW, Wells P, Prandoni P, Buller HR. Noninvasive objective tests for the diagnosis of clinically suspected deep-vein thrombosis. Haemostasis25(1–2), 27–39 (1995).
   PubMedGoogle Scholar
• Mantoni M. Diagnosis of deep venous thrombosis by duplex sonography. Acta Radiol.30(6), 575–579 (1989).
   PubMed Web of Science ®Google Scholar
• Sampson FC, Goodacre SW, Thomas SM, van Beek EJ. The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur. Radiol.17(1), 175–181 (2007).
   PubMed Web of Science ®Google Scholar
• Das M, Muhlenbruch G, Mahnken AH et al. Optimized image reconstruction for detection of deep venous thrombosis at multidetector-row CT venography. Eur. Radiol.16(2), 269–275 (2006).
   PubMed Web of Science ®Google Scholar
• Goodman LR, Stein PD, Matta F et al. CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. AJR Am. J. Roentgenol.189(5), 1071–1076 (2007).
   PubMed Web of Science ®Google Scholar
• Marsh JD, Glynn M, Torman HA. Pulmonary angiography. Application in a new spectrum of patients. Am. J. Med.75(5), 763–770 (1983).
   PubMed Web of Science ®Google Scholar
• Zuckerman DA, Sterling KM, Oser RF. Safety of pulmonary angiography in the 1990s. J. Vasc. Interv. Radiol.7(2), 199–205 (1996).
   PubMed Web of Science ®Google Scholar
• Worsley DF, Alavi A. Comprehensive analysis of the results of the PIOPED Study. Prospective Investigation of Pulmonary Embolism Diagnosis Study. J. Nucl. Med.36(12), 2380–2387 (1995).
   PubMed Web of Science ®Google Scholar
• Lombard J, Bhatia R, Sala E. Spiral computed tomographic pulmonary angiography for investigating suspected pulmonary embolism: clinical outcomes. Can. Assoc. Radiol. J.54(3), 147–151 (2003).
   PubMed Web of Science ®Google Scholar
• Stein PD, Fowler SE, Goodman LR et al. Multidetector computed tomography for acute pulmonary embolism. N. Engl. J. Med.354(22), 2317–2327 (2006).
   PubMed Web of Science ®Google Scholar
• Babyn PS, Gahunia HK, Massicotte P. Pulmonary thromboembolism in children. Pediatr. Radiol.35(3), 258–274 (2005).
   PubMed Web of Science ®Google Scholar
• Monagle P, Chan A, Massicotte P, Chalmers E, Michelson AD. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126(3 Suppl.), 645S–687S (2004).
   Web of Science ®Google Scholar
• Newall F, Barnes C, Savoia H, Campbell J, Monagle P. Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics112(5), e386 (2003).
   Google Scholar
• Kearon C, Gent M, Hirsh J et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N. Engl. J. Med.340(12), 901–907 (1999).
   PubMed Web of Science ®Google Scholar
• Bjork I, Lindahl U. Mechanism of the anticoagulant action of heparin. Mol. Cell. Biochem.48(3), 161–182 (1982).
   PubMed Web of Science ®Google Scholar
• Casu B, Oreste P, Torri G et al. The structure of heparin oligosaccharide fragments with high anti-(Factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies. Biochem. J.197(3), 599–609 (1981).
   PubMed Web of Science ®Google Scholar
• Andrew M, Marzinotto V, Massicotte P et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr. Res.35(1), 78–83 (1994).
   PubMed Web of Science ®Google Scholar
• Bidlingmaier C, Magnani HN, Girisch M, Kurnik K. Safety and efficacy of danaparoid (Orgaran) use in children. Acta Haematol.115(3–4), 237–247 (2006).
   PubMed Web of Science ®Google Scholar
• Sackler JP, Liu L. Heparin-induced osteoporosis. Br. J. Radiol.46(547), 548–550 (1973).
   PubMed Web of Science ®Google Scholar
• Murphy MS, John PR, Mayer AD, Buckels JA, Kelly DA. Heparin therapy and bone fractures. Lancet340(8827), 1098 (1992).
   PubMed Web of Science ®Google Scholar
• Hirsh J, Levine MN. Low molecular weight heparin. Blood79(1), 1–17 (1992).
   PubMed Web of Science ®Google Scholar
• Kuhle S, Massicotte P, Dinyari M et al. Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric patients with thromboembolic events. Thromb. Haemost.94(6), 1164–1171 (2005).
   PubMed Web of Science ®Google Scholar
• Streif W, Goebel G, Chan AK, Massicotte MP. Use of low molecular mass heparin (enoxaparin) in newborn infants: a prospective cohort study of 62 patients. Arch. Dis. Child Fetal Neonatal Ed.88(5), F365–370 (2003).
   PubMed Web of Science ®Google Scholar
• Malowany JI, Knoppert DC, Chan AK, Pepelassis D, Lee DS. Enoxaparin use in the neonatal intensive care unit: experience over 8 years. Pharmacotherapy27(9), 1263–1271 (2007).
   PubMed Web of Science ®Google Scholar
• Andrew M, Paes B, Johnston M. Development of the hemostatic system in the neonate and young infant. Am. J. Pediatr. Hematol. Oncol.12(1), 95–104 (1990).
   PubMedGoogle Scholar
• Whitlon DS, Sadowski JA, Suttie JW. Mechanism of coumarin action: significance of vitamin K epoxide reductase inhibition. Biochemistry17(8), 1371–1377 (1978).
   PubMed Web of Science ®Google Scholar
• Choonara IA, Malia RG, Haynes BP et al. The relationship between inhibition of vitamin K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br. J. Clin. Pharmacol.25(1), 1–7 (1988).
   PubMed Web of Science ®Google Scholar
• Furie B, Furie BC. Molecular basis of vitamin K-dependent g-carboxylation. Blood75(9), 1753–1762 (1990).
   PubMed Web of Science ®Google Scholar
• Streif W, Andrew M, Marzinotto V et al. Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients. Blood94(9), 3007–3014 (1999).
   PubMed Web of Science ®Google Scholar
• Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann. Intern. Med.121(9), 676–683 (1994).
   PubMed Web of Science ®Google Scholar
• Shearer MJ, Rahim S, Barkhan P, Stimmler L. Plasma vitamin K1 in mothers and their newborn babies. Lancet2(8296), 460–463 (1982).
   PubMed Web of Science ®Google Scholar
• Greer FR, Mummah-Schendel LL, Marshall S, Suttie JW. Vitamin K1 (phylloquinone) and vitamin K2 (menaquinone) status in newborns during the first week of life. Pediatrics81(1), 137–140 (1988).
   PubMed Web of Science ®Google Scholar
• Haroon Y, Shearer MJ, Rahim S, Gunn WG, McEnery G, Barkhan P. The content of phylloquinone (vitamin K1) in human milk, cows’ milk and infant formula foods determined by high-performance liquid chromatography. J. Nutr.112(6), 1105–1117 (1982).
   PubMed Web of Science ®Google Scholar
• von Kries R, Shearer M, McCarthy PT, Haug M, Harzer G, Gobel U. Vitamin K1 content of maternal milk: influence of the stage of lactation, lipid composition, and vitamin K1 supplements given to the mother. Pediatr. Res.22(5), 513–517 (1987).
   PubMed Web of Science ®Google Scholar
• Severijnen R, Bayat N, Bakker H, Tolboom J, Bongaerts G. Enteral drug absorption in patients with short small bowel : a review. Clin. Pharmacokinet.43(14), 951–962 (2004).
   PubMed Web of Science ®Google Scholar
• Marzinotto V, Monagle P, Chan A et al. Capillary whole blood monitoring of oral anticoagulants in children in outpatient clinics and the home setting. Pediatr. Cardiol.21(4), 347–352 (2000).
   PubMed Web of Science ®Google Scholar
• Newall F, Monagle P, Johnston L. Home INR monitoring of oral anticoagulant therapy in children using the CoaguChek S point-of-care monitor and a robust education program. Thromb. Res.118(5), 587–593 (2006).
   PubMed Web of Science ®Google Scholar
• Ignjatovic V, Barnes C, Newall F, Hamilton S, Burgess J, Monagle P. Point of care monitoring of oral anticoagulant therapy in children: comparison of CoaguChek Plus and Thrombotest methods with venous international normalised ratio. Thromb. Haemost.92(4), 734–737 (2004).
   PubMed Web of Science ®Google Scholar
• Barnes C, Newall F, Ignjatovic V et al. Reduced bone density in children on long-term warfarin. Pediatr. Res.57(4), 578–581 (2005).
   PubMed Web of Science ®Google Scholar
• Weitz JI, Hirsh J, Samama MM. New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest126(3 Suppl), 265S–286S (2004).
   PubMed Web of Science ®Google Scholar
• Hursting MJ, Dubb J, Verme-Gibboney CN. Argatroban anticoagulation in pediatric patients: a literature analysis. J. Pediatr. Hematol. Oncol.28(1), 4–10 (2006).
   PubMed Web of Science ®Google Scholar
• Almond CS, Harrington J, Thiagarajan R et al. Successful use of bivalirudin for cardiac transplantation in a child with heparin-induced thrombocytopenia. J. Heart Lung Transplant.25(11), 1376–1379 (2006).
   PubMed Web of Science ®Google Scholar
• Young G, Tarantino MD, Wohrley J, Weber LC, Belvedere M, Nugent DJ. Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis. J. Thromb. Haemost.5(8), 1654–1659 (2007).
   PubMed Web of Science ®Google Scholar
• Young G, Boshkov LK. Prospective study of direct thrombin inhibition with argatroban in pediatric patients requiring nonheparin anticoagulation. Presented at:49th Annual Meeting of the American Society of Hematology.Atlanta, GA, USA, 8 December–11 December 2007.
   Google Scholar
• Herbert JM, Herault JP, Bernat A et al. Biochemical and pharmacological properties of SANORG 34006, a potent and long-acting synthetic pentasaccharide. Blood91(11), 4197–4205 (1998).
   PubMed Web of Science ®Google Scholar
• Albisetti M. Thrombolytic therapy in children. Thromb. Res.118(1), 95–105 (2006).
   PubMed Web of Science ®Google Scholar
• Monagle P, Adams M, Mahoney M et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr. Res.47(6), 763–766 (2000).
   PubMed Web of Science ®Google Scholar
• Goldenberg NA, Knapp-Clevenger R, Manco-Johnson MJ. Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis in children. N. Engl. J. Med.351(11), 1081–1088 (2004).
   PubMed Web of Science ®Google Scholar
• Rutherford RB. Pathogenesis and pathophysiology of the post-thrombotic syndrome: clinical implications. Semin. Vasc. Surg.9(1), 21–25 (1996).
   PubMedGoogle Scholar
• Kuhle S, Koloshuk B, Marzinotto V et al. A cross-sectional study evaluating post-thrombotic syndrome in children. Thromb. Res.111(4–5), 227–233 (2003).
   PubMed Web of Science ®Google Scholar